Results 121 to 130 of about 11,647 (179)

Ferroptosis as an approach to leverage cancer metabolism. [PDF]

Trends Cell Biol
Jin J, Hu J, Li M, Gu W, Jiang X, Stockwell BR.   +5 more
europepmc   +1 more source

Leukemia-expanded splenic CD81+ erythroblasts potentiate disease progression in mice by reshaping leukemic cell metabolism. [PDF]

J Clin Invest
Li Y, Cao J, Tong J, Tang P, Chen H, Sun G, Yang Z, Zhang X, Dong F, Yang S, Gao J, Zhao X, Ma J, Wang D, Zhang L, Wang L, Cheng T, Cheng H, Shi L.   +18 more
europepmc   +1 more source

Non-Targeted Plasma Lipidomic Profiling in Late Pregnancy and Early Postpartum Stages: An Observational Comparative Study. [PDF]

Metabolites
Traila A, Abu-Awwad SA, Marta CI, Bacanoiu MV, Maghiari AL, Abu-Awwad A, Craina ML.   +6 more
europepmc   +1 more source

Maternal urinary metabolomic signatures preceding spontaneous preterm birth: A pilot study. [PDF]

Sci Rep
Thangavelu MU, Ronde E, Lamont L, Elfrink HL, Harms A, de Rijke YB, Franx A, de Meij TGJ, Kindt A, Reiss IKM, Schoenmakers S, Hankemeier T.   +11 more
europepmc   +1 more source

Metabolomics reveal drought-stress responses in guayule, a semi-arid rubber crop. [PDF]

Metabolomics
Phan H, Abdel-Haleem H.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chaperone-like Properties of Lysophospholipids

Biochemical and Biophysical Research Communications, 2001
Lysophospholipids are metabolic intermediates in phospholipid turnover, detergent molecules with membrane-modulating effects, and multifunctional cellular growth factors in eukaryotic cells. In bacterial cells, lysophospholipids are mostly found in the form of lysophosphatidylethanolamine.
Gilbert Richarme, Renee Kern, M K Chattopadhyay   +2 more
exaly   +3 more sources

Lysophospholipid Receptors

Annual Review of Pharmacology and Toxicology, 2001
Lysophospholipids (LPs), including lysophosphatidic acid and sphingosine 1-phosphate, produce many cellular effects. However, the prolonged absence of any cloned and identified LP receptor has left open the question of how these lipids actually bring about these effects.
N, Fukushima, I, Ishii, J J, Contos, J A, Weiner, J, Chun   +4 more
openaire   +3 more sources

Lysophospholipids--Receptor Revelations

Science, 2001
Upon cell activation, membrane phospholipids are metabolized into potent lysophospholipid (LP) mediators, such as sphingosine 1-phosphate and lysophosphatidic acid. LPs fulfill signaling roles in organisms as diverse as yeast and humans. The recent discovery of G protein–coupled receptors for LPs in higher eukaryotes, and their involvement in ...
T, Hla, M J, Lee, N, Ancellin, J H, Paik, M J, Kluk   +4 more
openaire   +2 more sources

Mechanisms of cardioprotection by lysophospholipids

Journal of Cellular Biochemistry, 2004
AbstractThe lysophospholipids sphingosine 1‐phosphate (S1P) and lysophosphosphatidic acid (LPA) reduce mortality in hypoxic cardiac myocytes. S1P is also cardioprotective in both mouse and rat models of cardiac ischemia/reperfusion (I/R) injury. Although these results are consistent with prior work in other cell types, it is not known what signaling ...
openaire   +2 more sources